newsfilter
← Latest News
PR Newswire·

Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 9, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies,